Citation: Ma. Kolber et al., IN-VITRO ENHANCEMENT OF T-CELL RECEPTOR-TARGETED LYSIS AFTER IL-2 TREATMENT OF PBL FROM HIV-SEROPOSITIVE INDIVIDUALS, Clinical immunology and immunopathology, 86(2), 1998, pp. 226-234
Authors:
TRUGO LC
CARVALHO CWP
PINTO M
CABRAL L
MODESTA RCD
Citation: Lc. Trugo et al., EFFECT OF MALTING AND EXTRUSION ON THE QUALITY OF DERIVED PRODUCTS OFSOYBEAN, Archivos latinoamericanos de nutricion, 48(2), 1998, pp. 169-174
Authors:
HARRINGTON WJ
SIECZKOWSKI L
SOSA C
CHANASUE S
CAI JP
CABRAL L
WOOD C
Citation: Wj. Harrington et al., ACTIVATION OF HHV-8 (KSHV) BY HIV-1 TAT, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 69-69
Authors:
HARRINGTON WJ
CABRAL L
CAI JP
CHANASUE S
WOOD C
Citation: Wj. Harrington et al., AZOTHYMIDINE AND INTERFERON-ALPHA ARE ACTIVE IN AIDS-ASSOCIATED SMALLNON-CLEAVED CELL LYMPHOMA BUT NOT LARGE-CELL LYMPHOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 94-94
Authors:
RAEZ L
HURLEY J
JAYAWERA D
SCERPELLA E
LANDY H
CAI J
SFAKANAKIS G
CABRAL L
HARRINGTON W
Citation: L. Raez et al., RELATED PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS WITH AZOTHYMIDINE, GANCICLOVIR AND INTERLEUKIN-2, Blood, 90(10), 1997, pp. 1524-1524
Authors:
PATARCA R
FRIEDLANDER A
HARRINGTON WJ
CABRAL L
BYRNES JJ
FLETCHER MA
Citation: R. Patarca et al., PERIPHERAL-BLOOD T-CELL SUBSETS AS PROGNOSTIC INDICATORS OF CHEMOTHERAPY OUTCOME IN AIDS PATIENTS WITH LARGE-CELL LYMPHOMA, AIDS research and human retroviruses, 12(8), 1996, pp. 645-649
Authors:
HARRINGTON WJ
CABRAL L
CAI JP
CHANASUE S
WOOD C
Citation: Wj. Harrington et al., AZOTHYMIDINE AND INTERFERON-ALPHA ARE ACTIVE IN AIDS-ASSOCIATED SMALLNON-CLEAVED CELL LYMPHOMA BUT NOT LARGE-CELL LYMPHOMA, Lancet, 348(9030), 1996, pp. 833-833
Authors:
HARRINGTON WJ
BAGASRA O
SOSA CE
BOBROSKI LE
BAUM M
WEN XL
CABRAL L
BYRNE GE
POMERANTZ RJ
WOOD C
Citation: Wj. Harrington et al., HUMAN HERPESVIRUS TYPE-8 DNA-SEQUENCES IN CELL-FREE PLASMA AND MONONUCLEAR-CELLS OF KAPOSIS-SARCOMA PATIENTS, The Journal of infectious diseases, 174(5), 1996, pp. 1101-1105
Authors:
HARRINGTON WJ
UCAR A
GILL P
SNODGRASS S
SHEREMATA W
CABRAL L
RABIN M
BYRNE GE
BERGER J
VOIGHT W
KEMPER R
MILLER G
WHITCOMB CC
GREENBERG A
BYRNES JJ
POIESZ B
Citation: Wj. Harrington et al., CLINICAL SPECTRUM OF HTLV-I IN SOUTH FLORIDA, Journal of acquired immune deficiency syndromes and human retrovirology, 8(5), 1995, pp. 466-473
Authors:
GILL PS
HARRINGTON W
KAPLAN MH
RIBEIRO RC
BENNETT JM
LIEBMAN HA
BERNSTEINSINGER M
ESPINA BM
CABRAL L
ALLEN S
KORNBLAU S
PIKE MC
LEVINE AM
Citation: Ps. Gill et al., TREATMENT OF ADULT T-CELL LEUKEMIA-LYMPHOMA WITH A COMBINATION OF INTERFERON-ALFA AND ZIDOVUDINE, The New England journal of medicine, 332(26), 1995, pp. 1744-1748
Authors:
HARRINGTON W
GILL P
CABRAL L
WEN X
WOOD C
Citation: W. Harrington et al., COMBINATION ANTIVIRAL THERAPY FOR ADULT T-CELL LEUKEMIA LYMPHOMA/, AIDS research and human retroviruses, 10(4), 1994, pp. 476-476
Authors:
HARRINGTON W
PATARCA R
BYRNES J
CABRAL L
LAI S
VENET T
COHEN J
KLIMAS NG
FLETCHER MA
Citation: W. Harrington et al., BASE-LINE CD8 COUNTS AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH HIV-ASSOCIATED LYMPHOMAS UNDERGOING CHEMOTHERAPY, Blood, 82(10), 1993, pp. 10000566-10000566